Form 4 holding
Director
ABBOTT LABORATORIES
- Security class
- Common shares without par value
- Shares / value
- 6,751,103
- Estimated value
- $625,514,672
- Report date
- 27 Apr 2026
- Price
- $92.65
- Ownership
- Direct
Daniel J. Starks
Insider Reports History
- Reporting-owner location
- St Paul, MN
- Latest reporting-owner signature
- /s/ Daniel J. Starks by Jessica H. Paik, Attorney-in-Fact
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Daniel J. Starks
Form 4 holding
Director
ABBOTT LABORATORIES
- Security class
- Common shares without par value
- Shares / value
- 258
- Estimated value
- $26,488
- Report date
- 24 Apr 2026
- Price
- $102.67
- Ownership
- Alynne Starks 2012 Irrevocable Trust
Form 4 holding
Director
ABBOTT LABORATORIES
- Security class
- Option (right to buy)
- Shares / value
- 7,105
- Estimated value
- Report date
- 24 Apr 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
Insider Reports Filed by Daniel J. Starks
4
ABT
ABBOTT LABORATORIES
- Report period
- 24 Apr 2026
- Transactions
- 3
- Transaction value
- +$926,537
- Accepted by SEC
- 28 Apr 2026, 19:37
- Role
- Director
- Next action
- Open filing details
4
ABT
ABBOTT LABORATORIES
- Report period
- 04 Feb 2026
- Transactions
- 2
- Transaction value
- +$1,087,331
- Accepted by SEC
- 06 Feb 2026, 08:04
- Role
- Director
- Next action
- Open filing details
4
ABT
ABBOTT LABORATORIES
- Report period
- 25 Apr 2025
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 29 Apr 2025, 18:22
- Role
- Director
- Next action
- Open filing details
4
ABT
ABBOTT LABORATORIES
- Report period
- 26 Apr 2024
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 30 Apr 2024, 18:22
- Role
- Director
- Next action
- Open filing details
4
ABT
ABBOTT LABORATORIES
- Report period
- 26 Oct 2023
- Transactions
- 2
- Transaction value
- -$4,702,526
- Accepted by SEC
- 30 Oct 2023, 16:58
- Role
- Director
- Next action
- Open filing details
4
ABT
ABBOTT LABORATORIES
- Report period
- 27 Jul 2023
- Transactions
- 2
- Transaction value
- -$5,688,189
- Accepted by SEC
- 28 Jul 2023, 17:10
- Role
- Director
- Next action
- Open filing details
4
ABT
ABBOTT LABORATORIES
- Report period
- 28 Apr 2023
- Transactions
- 4
- Transaction value
- -$5,551,193
- Accepted by SEC
- 02 May 2023, 20:04
- Role
- Director
- Next action
- Open filing details
4
ABT
ABBOTT LABORATORIES
- Report period
- 27 Oct 2022
- Transactions
- 2
- Transaction value
- -$4,872,932
- Accepted by SEC
- 31 Oct 2022, 17:44
- Role
- Director
- Next action
- Open filing details
4
ABT
ABBOTT LABORATORIES
- Report period
- 26 Jul 2022
- Transactions
- 2
- Transaction value
- -$5,456,994
- Accepted by SEC
- 28 Jul 2022, 17:20
- Role
- Director
- Next action
- Open filing details
4
ABT
ABBOTT LABORATORIES
- Report period
- 03 May 2022
- Transactions
- 3
- Transaction value
- -$5,661,048
- Accepted by SEC
- 05 May 2022, 17:15
- Role
- Director
- Next action
- Open filing details
4
ABT
ABBOTT LABORATORIES
- Report period
- 29 Apr 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 03 May 2022, 18:23
- Role
- Director
- Next action
- Open filing details